share_log

HC Wainwright & Co. Reiterates Buy on Apellis Pharmaceuticals, Maintains $92 Price Target

HC Wainwright & Co. Reiterates Buy on Apellis Pharmaceuticals, Maintains $92 Price Target

HC Wainwright & Co.重申買入Apellis Pharmicals,維持92美元的目標股價
Moomoo 24/7 ·  04/15 07:07

HC Wainwright & Co. analyst Douglas Tsao reiterates Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and maintains $92 price target.

HC Wainwright & Co. 分析師道格拉斯·曹重申Apellis Pharmicals(納斯達克股票代碼:APLS)的買入並維持92美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論